CA2352759A1 - Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation - Google Patents

Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation Download PDF

Info

Publication number
CA2352759A1
CA2352759A1 CA002352759A CA2352759A CA2352759A1 CA 2352759 A1 CA2352759 A1 CA 2352759A1 CA 002352759 A CA002352759 A CA 002352759A CA 2352759 A CA2352759 A CA 2352759A CA 2352759 A1 CA2352759 A1 CA 2352759A1
Authority
CA
Canada
Prior art keywords
polypeptide
ser
thr
gly
leu
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002352759A
Other languages
English (en)
Inventor
Joe Wang
Andrew D. Murdin
Raymond P. Oomen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2352759A1 publication Critical patent/CA2352759A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des molécules polynucléotidiques purifiées et isolées qui codent pour les polypeptides de Chlamydia. Ces molécules peuvent s'utiliser dans des procédés pour prévenir, traiter et diagnostiquer les infections par Chlamydia. Dans une forme de l'invention, les molécules polynucléotidiques sont choisies à partir des ADN qui codent pour les polypeptides CPN100634 (SEQ ID Nos: 1, 2 et 11), CPN100635 (SEQ ID Nos: 3, 4, 12 et 13), CPN100638 (SEQ ID Nos: 5, 6 et 14), CPN100639 (SEQ ID Nos: 7, 8 et 15), CPN100708 (SEQ ID Nos: 9, 10 et 16).
CA002352759A 1998-12-01 1999-12-01 Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation Abandoned CA2352759A1 (fr)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US11042898P 1998-12-01 1998-12-01
US11033998P 1998-12-01 1998-12-01
US11034098P 1998-12-01 1998-12-01
US11042798P 1998-12-01 1998-12-01
US11043898P 1998-12-01 1998-12-01
US60/110,438 1998-12-01
US60/110,427 1998-12-01
US60/110,339 1998-12-01
US60/110,340 1998-12-01
US60/110,428 1998-12-01
PCT/CA1999/001147 WO2000032794A2 (fr) 1998-12-01 1999-12-01 Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation

Publications (1)

Publication Number Publication Date
CA2352759A1 true CA2352759A1 (fr) 2000-06-08

Family

ID=27537275

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002352759A Abandoned CA2352759A1 (fr) 1998-12-01 1999-12-01 Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation

Country Status (6)

Country Link
EP (1) EP1135509A2 (fr)
JP (1) JP2002531095A (fr)
AU (1) AU1540500A (fr)
CA (1) CA2352759A1 (fr)
NZ (1) NZ512308A (fr)
WO (1) WO2000032794A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249233C (zh) * 1997-06-23 2006-04-05 洛克诊断Aps 肺炎衣原体表面蛋白
KR20010032336A (ko) * 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도

Also Published As

Publication number Publication date
JP2002531095A (ja) 2002-09-24
EP1135509A2 (fr) 2001-09-26
WO2000032794A3 (fr) 2000-11-09
NZ512308A (en) 2004-01-30
AU1540500A (en) 2000-06-19
WO2000032794A2 (fr) 2000-06-08

Similar Documents

Publication Publication Date Title
EP1240331B1 (fr) Antigenes anti- chlamydia, fragments d'adn correspondants et leurs utilisations
CA2385325C (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisations
US20040086525A1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2001021810A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et leurs utilisations
US6521745B1 (en) Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
NZ529361A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US6808713B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US20020099188A1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2365196C (fr) Antigenes (chlamydia), fragments d'adn correspondants, et leurs utilisations
US7850980B2 (en) Chlamydia OMP antigen
US6607730B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US7297341B1 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
US6686339B1 (en) Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
AU774902B2 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2352759A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants et leur utilisation
CA2341637A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants et leur utilisation
US20080112965A1 (en) Chlamydia OMP antigen
WO2001021803A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants et utilisations de ces derniers
WO2001002575A1 (fr) Antigenes anti-chlamydia, leurs fragments d'adn correspondants et leurs utilisations
AU1851700A (en) (Chlamydia) antigens and corresponding dna fragments and uses thereof
WO2001021802A1 (fr) Antigenes de chlamydia et fragments d'adn correspondants et utilisations de ceux-ci
WO2001021805A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants, et utilisations desdits fragments
WO2000053764A1 (fr) Antigenes de chlamydia, fragments d'adn correspondants, et leurs utilisations
WO2001021806A1 (fr) Antigenes anti-chlamydia, fragments d'adn correspondants et leurs utilisations

Legal Events

Date Code Title Description
FZDE Discontinued